ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,417 | -47.9% | 27,056 | 0.0% | 0.00% | – |
| Q2 2023 | $117,964 | +51.2% | 27,056 | +98.5% | 0.00% | – |
| Q1 2022 | $78,000 | -41.4% | 13,630 | 0.0% | 0.00% | – |
| Q4 2021 | $133,000 | -90.8% | 13,630 | +0.4% | 0.00% | -100.0% |
| Q3 2021 | $1,438,000 | +24.1% | 13,579 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $1,159,000 | -12.4% | 13,579 | +17.8% | 0.00% | -33.3% |
| Q1 2021 | $1,323,000 | -13.6% | 11,527 | +5.3% | 0.00% | 0.0% |
| Q4 2020 | $1,532,000 | +124.0% | 10,944 | +30.3% | 0.00% | +50.0% |
| Q3 2020 | $684,000 | +13.4% | 8,398 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $603,000 | +37.7% | 8,398 | -14.7% | 0.00% | 0.0% |
| Q1 2020 | $438,000 | -52.6% | 9,844 | +1.6% | 0.00% | -50.0% |
| Q4 2019 | $924,000 | +55.3% | 9,693 | +28.0% | 0.00% | +100.0% |
| Q3 2019 | $595,000 | +107.3% | 7,570 | +14.4% | 0.00% | 0.0% |
| Q2 2019 | $287,000 | +27.0% | 6,618 | +18.9% | 0.00% | 0.0% |
| Q1 2019 | $226,000 | – | 5,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |